Skip to main navigation Skip to search Skip to main content

Circulating fibroblast growth factor 23 (FGF23) levels are associated with metabolic disturbances and fat distribution but not cardiovascular risk in HIV-infected patients

Pere Domingo, Maria Karuna Lamarca, José M. Gallego-Escuredo, Ferran Torres, Joan C. Domingo, Joan Villarroya, Ma Del Mar Gutierrez, Ma Gracia Mateo, Francesc Vidal, Francesc Villarroya, Marta Giralt

Research output: Contribution to journal › Article › Research › peer-review

14   Link opens in a new tab Citations (Scopus)

Fingerprint

Dive into the research topics of 'Circulating fibroblast growth factor 23 (FGF23) levels are associated with metabolic disturbances and fat distribution but not cardiovascular risk in HIV-infected patients'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology